Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ESPRESPR
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ESPERION THERAPEUTICS INC NE

GOLDMAN SACHS GROUP INC holds 10.4M shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $32.8M as of 2026-Q2. The position was increased (+330.6% shares). ESPR represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$32.8M

Current Shares

10.4M

Total Value Change

+$26.7M

Total Shares Change

+7.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
10.4M
+330.6%
$32.8M0.0%$3.16
47
2026-Q1
Decreased
2.4M
-15.4%
$6.6M0.0%$2.91
0
2025-Q4
Increased
2.8M
+66.7%
$10.5M0.0%$3.69
41
2025-Q3
Increased
1.7M
+113.9%
$4.5M0.0%$2.64
43
2025-Q2
Decreased
798,754
-47.7%
$786,2930.0%$0.99
0
2025-Q1
Decreased
1.5M
-44.5%
$2.2M0.0%$1.50
0
2024-Q4
New
2.8M
-
$6.1M0.0%$2.15
38

Other major holders of ESPR: BNP PARIBAS FINANCIAL MARKETS, Pentwater Capital Management LP, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used